Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stuyver

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Archives of Virology|February 4, 1999
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus TaxonomyB Robertson, G Myers, C Howard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populationsK Van Laethem, K Van Vaerenbergh, J C Schmit, et al.
Journal of Hepatology|November 1, 1996
HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy)S Magrin, A Craxi, C Fabiano, et al.
Journal of Clinical Microbiology|March 21, 1998
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from VenezuelaL Blitz, F H Pujol, P D Swenson, et al.
AIDS Research and Human Retroviruses|April 25, 2000
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapyK Van Vaerenbergh, K Van Laethem, E Van Wijngaerden, et al.
Antiviral Therapy|June 22, 2001
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in BelgiumK Van Vaerenbergh, L Debaisieux, N De Cabooter, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analoguesK Van Vaerenbergh, K Van Laethem, J Albert, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Archives of Virology|February 4, 1999
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus TaxonomyB Robertson, G Myers, C Howard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populationsK Van Laethem, K Van Vaerenbergh, J C Schmit, et al.
Journal of Hepatology|November 1, 1996
HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy)S Magrin, A Craxi, C Fabiano, et al.
Journal of Clinical Microbiology|March 21, 1998
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from VenezuelaL Blitz, F H Pujol, P D Swenson, et al.
AIDS Research and Human Retroviruses|April 25, 2000
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapyK Van Vaerenbergh, K Van Laethem, E Van Wijngaerden, et al.
Antiviral Therapy|June 22, 2001
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in BelgiumK Van Vaerenbergh, L Debaisieux, N De Cabooter, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analoguesK Van Vaerenbergh, K Van Laethem, J Albert, et al.
Pageof 5